Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 11-18 of 18

Page
per page
  1. Poloxime
    B3609 Poloxime
    Summary: polo-like kinase 1 （PLK) analogue
      Soluble in DMSO
  2. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  3. 3MB-PP1
    C3340 3MB-PP1
    Summary: polo-like kinase 1 (Plk1) allele inhibitor,ATP-competitive
      ≤2 mg/mL
  4. SBE 13 HCl
    B5857 SBE 13 HCl
    Target: PLK
    Summary: Inactive Plk1 inhibitor
      Soluble in DMSO
  5. TAK960
    B5860 TAK960
    Target: PLK
    Summary: Oral and selective PLK1 inhibitor
      ≥28.05 mg/mL
  6. CFI-400945
    C5813 CFI-400945
    Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
      insoluble in H2O; ≥109.8 mg/mL
  7. Cyclapolin 9
    B7279 Cyclapolin 9
    Summary: PLK1 inhibitor
      <7.68 mg/mL
  8. TC-S 7005
    B5604 TC-S 7005
    Summary: polo-like kinase 2 (PLK2) inhibitor
      <35.94 mg/mL

Items 11-18 of 18

Page
per page